blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2340022

EP2340022 - COMBINATION THERAPY FOR TUBERCULOSIS [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  15.04.2019
Database last updated on 24.08.2024
FormerThe patent has been granted
Status updated on  24.01.2017
Most recent event   Tooltip19.07.2017Change - representative 
Applicant(s)For all designated states
Pfizer Inc.
235 East 42nd Street
New York, NY 10017 / US
For all designated states
The Johns Hopkins University
3400 North Charles Street
Baltimore, MD 21218 / US
[2013/47]
Former [2011/27]For all designated states
Pfizer Inc.
235 East 42nd Street
New York, NY 10017 / US
For all designated states
The Johns Hopkins University
3400 North Charles Street
Baltimore, MD 21218 / US
Former [2011/27]For all designated states
Pfizer Inc.
235 East 42nd Street
New York, NY 10017 / US
Inventor(s)01 / BRICKNER, Steven Joseph
9 Fargo Drive
Ledyard Connecticut 06339 / US
02 / NUERMBERGER, Eric
1550 Orleans Street
Rm. 108
Baltimore Maryland 21231 / US
03 / STOVER, Charles Kendall
734 Turtle Pond Lane
Gaithersburg Maryland 20878 / US
 [2013/47]
Former [2011/27]01 / BRICKNER, Steven Joseph
9 Fargo Drive
Ledyard Connecticut 06339 / US
02 / NUERMBERGER, Eric
1550 Orleans Street Rm. 108
Baltimore Maryland 21231 / US
03 / STOVER, Charles Kendall
734 Turtle Pond Lane
Gaithersburg Maryland 20878 / US
Representative(s)Johansson, Lars-Erik
Hynell Intellectual Property AB
Hammarbybacken 27
120 30 Stockholm / SE
[N/P]
Former [2013/47]Johansson, Lars-Erik
Hynell Patenttjänst AB
Box 138
683 23 Hagfors / SE
Former [2013/37]Johansson, Lars-Erik
Hynell Patenttjänst AB Patron Carls väg 2
683 40 Uddeholm / SE
Former [2012/33]Pfizer
European Patent Department
23-25 avenue du Docteur Lannelongue
75668 Paris Cedex 14 / FR
Former [2011/51]Lane, Graham Mark Hamilton, et al
Pfizer
European Patent Department
23-25, avenue du Docteur Lannelongue
75668 Paris Cedex 14 / FR
Former [2011/27]Kingsbury, Oliver William
Pfizer Limited European Patent Department Ramsgate Road Sandwich
Kent CT13 9NJ / GB
Application number, filing date09787058.831.08.2009
[2011/27]
WO2009IB53796
Priority number, dateUS20080093879P03.09.2008         Original published format: US 93879 P
[2011/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010026526
Date:11.03.2010
Language:EN
[2010/10]
Type: A1 Application with search report 
No.:EP2340022
Date:06.07.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 11.03.2010 takes the place of the publication of the European patent application.
[2011/27]
Type: B1 Patent specification 
No.:EP2340022
Date:20.11.2013
Language:EN
[2013/47]
Search report(s)International search report - published on:EP11.03.2010
ClassificationIPC:A61K31/4409, A61K31/4709, A61K31/496, A61K31/4965, A61K31/5377, A61K31/541, A61K45/06, A61P31/06
[2011/27]
CPC:
A61K31/541 (EP,US); A61K31/54 (KR); A61K31/421 (KR);
A61K31/4409 (EP,US); A61K31/4709 (EP,US); A61K31/496 (EP,US);
A61K31/4965 (EP,US); A61K31/5377 (EP,KR,US); A61K45/06 (EP,US);
A61P31/06 (EP); A61P43/00 (EP) (-)
C-Set:
A61K31/4409, A61K2300/00 (EP,US);
A61K31/4709, A61K2300/00 (US,EP);
A61K31/4965, A61K2300/00 (US,EP);
A61K31/496, A61K2300/00 (US,EP);
A61K31/5377, A61K2300/00 (EP,US);
A61K31/541, A61K2300/00 (EP,US)
(-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/27]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:KOMBINATIONSTHERAPIE GEGEN TUBERKULOSE[2011/27]
English:COMBINATION THERAPY FOR TUBERCULOSIS[2011/27]
French:THÉRAPIE COMBINÉE POUR LA TUBERCULOSE[2011/27]
Entry into regional phase04.04.2011National basic fee paid 
04.04.2011Designation fee(s) paid 
04.04.2011Examination fee paid 
Examination procedure04.04.2011Examination requested  [2011/27]
13.10.2011Amendment by applicant (claims and/or description)
16.08.2012Despatch of a communication from the examining division (Time limit: M06)
07.02.2013Reply to a communication from the examining division
12.06.2013Communication of intention to grant the patent
14.10.2013Fee for grant paid
14.10.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  16.08.2012
Opposition(s)Opponent(s)01  15.08.2014  20.08.2014  ADMISSIBLE
Generics [UK] Limited
(trading as Mylan)
Albany Gate
Darkes Lane
Potters Bar
Hertfordshire EN6 1AG / GB
Opponent's representative
Ter Meer Steinmeister & Partner, et al, et al
Patentanwälte mbB
Nymphenburger Straße 4
80335 München / DE
 02  20.08.2014  26.08.2014  ADMISSIBLE
Dr Klusmann Peter
Hoffmann Eitle
Arabellastrasse 4
81925 München / DE
Opponent's representative
Hoffmann Eitle, et al, et al
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
 [2015/50]
Former [2014/39]
Opponent(s)01  15.08.2014  20.08.2014  ADMISSIBLE
Generics [UK] Limited
(trading as Mylan)
Albany Gate
Darkes Lane
Potters Bar
Hertfordshire EN6 1AG / GB
Opponent's representative
Gallafent, Alison, et al, et al
Alison Gallafent Ltd
4 George Street
Llandeilo
SA19 6AS / GB
 02  20.08.2014    ADMISSIBLE
Dr Klusmann Peter
Hoffmann Eitle
Arabellastrasse 4
81925 München / DE
Opponent's representative
HOFFMANN EITLE, et al, et al
Patent- und Rechtsanwälte
Arabellastrasse 4
81925 München / DE
24.10.2014Invitation to proprietor to file observations on the notice of opposition
14.04.2015Reply of patent proprietor to notice(s) of opposition
15.11.2016Date of oral proceedings
25.01.2017Despatch of minutes of oral proceedings
25.01.2017Despatch of communication that the patent will be revoked
23.05.2017Legal effect of revocation of patent [2017/31]
Appeal following opposition27.03.2017Appeal received No.  T0789/17
23.05.2017Result of appeal procedure: appeal of the proprietor withdrawn
Fees paidRenewal fee
31.08.2011Renewal fee patent year 03
31.08.2012Renewal fee patent year 04
08.08.2013Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU31.08.2009
AT20.11.2013
BE20.11.2013
BG20.11.2013
CY20.11.2013
CZ20.11.2013
DK20.11.2013
EE20.11.2013
ES20.11.2013
FI20.11.2013
HR20.11.2013
IT20.11.2013
LT20.11.2013
LV20.11.2013
MC20.11.2013
MT20.11.2013
NL20.11.2013
PL20.11.2013
RO20.11.2013
SE20.11.2013
SI20.11.2013
SK20.11.2013
SM20.11.2013
TR20.11.2013
NO20.02.2014
GR21.02.2014
IS20.03.2014
PT20.03.2014
CH31.08.2014
IE31.08.2014
LI31.08.2014
LU31.08.2014
[2016/33]
Former [2016/32]HU31.08.2009
AT20.11.2013
BE20.11.2013
BG20.11.2013
CY20.11.2013
CZ20.11.2013
DK20.11.2013
EE20.11.2013
ES20.11.2013
FI20.11.2013
HR20.11.2013
IT20.11.2013
LT20.11.2013
LV20.11.2013
MC20.11.2013
MT20.11.2013
NL20.11.2013
PL20.11.2013
RO20.11.2013
SE20.11.2013
SI20.11.2013
SK20.11.2013
SM20.11.2013
NO20.02.2014
GR21.02.2014
IS20.03.2014
PT20.03.2014
CH31.08.2014
IE31.08.2014
LI31.08.2014
LU31.08.2014
Former [2016/31]AT20.11.2013
BE20.11.2013
BG20.11.2013
CY20.11.2013
CZ20.11.2013
DK20.11.2013
EE20.11.2013
ES20.11.2013
FI20.11.2013
HR20.11.2013
IT20.11.2013
LT20.11.2013
LV20.11.2013
MC20.11.2013
MT20.11.2013
NL20.11.2013
PL20.11.2013
RO20.11.2013
SE20.11.2013
SI20.11.2013
SK20.11.2013
SM20.11.2013
NO20.02.2014
GR21.02.2014
IS20.03.2014
PT20.03.2014
CH31.08.2014
IE31.08.2014
LI31.08.2014
LU31.08.2014
Former [2016/28]AT20.11.2013
BE20.11.2013
BG20.11.2013
CZ20.11.2013
DK20.11.2013
EE20.11.2013
ES20.11.2013
FI20.11.2013
HR20.11.2013
IT20.11.2013
LT20.11.2013
LV20.11.2013
MC20.11.2013
MT20.11.2013
NL20.11.2013
PL20.11.2013
RO20.11.2013
SE20.11.2013
SI20.11.2013
SK20.11.2013
SM20.11.2013
NO20.02.2014
GR21.02.2014
IS20.03.2014
PT20.03.2014
CH31.08.2014
IE31.08.2014
LI31.08.2014
LU31.08.2014
Former [2016/22]AT20.11.2013
BE20.11.2013
CZ20.11.2013
DK20.11.2013
EE20.11.2013
ES20.11.2013
FI20.11.2013
HR20.11.2013
IT20.11.2013
LT20.11.2013
LV20.11.2013
MC20.11.2013
NL20.11.2013
PL20.11.2013
RO20.11.2013
SE20.11.2013
SI20.11.2013
SK20.11.2013
SM20.11.2013
NO20.02.2014
IS20.03.2014
PT20.03.2014
CH31.08.2014
IE31.08.2014
LI31.08.2014
LU31.08.2014
Former [2015/37]AT20.11.2013
BE20.11.2013
CZ20.11.2013
DK20.11.2013
EE20.11.2013
ES20.11.2013
FI20.11.2013
HR20.11.2013
IT20.11.2013
LT20.11.2013
LV20.11.2013
MC20.11.2013
NL20.11.2013
PL20.11.2013
RO20.11.2013
SE20.11.2013
SI20.11.2013
SK20.11.2013
NO20.02.2014
IS20.03.2014
PT20.03.2014
CH31.08.2014
IE31.08.2014
LI31.08.2014
LU31.08.2014
Former [2015/22]AT20.11.2013
BE20.11.2013
CZ20.11.2013
DK20.11.2013
EE20.11.2013
ES20.11.2013
FI20.11.2013
HR20.11.2013
IT20.11.2013
LT20.11.2013
LV20.11.2013
MC20.11.2013
NL20.11.2013
PL20.11.2013
RO20.11.2013
SE20.11.2013
SI20.11.2013
SK20.11.2013
NO20.02.2014
IS20.03.2014
PT20.03.2014
CH31.08.2014
LI31.08.2014
LU31.08.2014
Former [2015/20]AT20.11.2013
BE20.11.2013
CZ20.11.2013
DK20.11.2013
EE20.11.2013
ES20.11.2013
FI20.11.2013
HR20.11.2013
LT20.11.2013
LV20.11.2013
MC20.11.2013
NL20.11.2013
PL20.11.2013
RO20.11.2013
SE20.11.2013
SI20.11.2013
SK20.11.2013
NO20.02.2014
IS20.03.2014
PT20.03.2014
CH31.08.2014
LI31.08.2014
LU31.08.2014
Former [2015/19]AT20.11.2013
BE20.11.2013
CZ20.11.2013
DK20.11.2013
EE20.11.2013
ES20.11.2013
FI20.11.2013
HR20.11.2013
LT20.11.2013
LV20.11.2013
MC20.11.2013
NL20.11.2013
PL20.11.2013
RO20.11.2013
SE20.11.2013
SI20.11.2013
SK20.11.2013
NO20.02.2014
IS20.03.2014
PT20.03.2014
LU31.08.2014
Former [2015/18]AT20.11.2013
BE20.11.2013
CZ20.11.2013
DK20.11.2013
EE20.11.2013
ES20.11.2013
FI20.11.2013
HR20.11.2013
LT20.11.2013
LV20.11.2013
MC20.11.2013
NL20.11.2013
PL20.11.2013
RO20.11.2013
SE20.11.2013
SI20.11.2013
SK20.11.2013
NO20.02.2014
IS20.03.2014
PT20.03.2014
Former [2015/14]AT20.11.2013
BE20.11.2013
CZ20.11.2013
DK20.11.2013
EE20.11.2013
ES20.11.2013
FI20.11.2013
HR20.11.2013
LT20.11.2013
LV20.11.2013
NL20.11.2013
PL20.11.2013
RO20.11.2013
SE20.11.2013
SI20.11.2013
SK20.11.2013
NO20.02.2014
IS20.03.2014
PT20.03.2014
Former [2014/41]AT20.11.2013
BE20.11.2013
CZ20.11.2013
DK20.11.2013
EE20.11.2013
ES20.11.2013
FI20.11.2013
HR20.11.2013
LT20.11.2013
LV20.11.2013
NL20.11.2013
PL20.11.2013
RO20.11.2013
SE20.11.2013
SK20.11.2013
NO20.02.2014
IS20.03.2014
PT20.03.2014
Former [2014/37]AT20.11.2013
BE20.11.2013
CZ20.11.2013
EE20.11.2013
ES20.11.2013
FI20.11.2013
HR20.11.2013
LT20.11.2013
LV20.11.2013
NL20.11.2013
PL20.11.2013
RO20.11.2013
SE20.11.2013
SK20.11.2013
NO20.02.2014
IS20.03.2014
PT20.03.2014
Former [2014/36]AT20.11.2013
BE20.11.2013
EE20.11.2013
ES20.11.2013
FI20.11.2013
HR20.11.2013
LT20.11.2013
LV20.11.2013
NL20.11.2013
SE20.11.2013
NO20.02.2014
IS20.03.2014
PT20.03.2014
Former [2014/28]AT20.11.2013
BE20.11.2013
ES20.11.2013
FI20.11.2013
HR20.11.2013
LT20.11.2013
LV20.11.2013
NL20.11.2013
SE20.11.2013
NO20.02.2014
IS20.03.2014
PT20.03.2014
Former [2014/26]AT20.11.2013
BE20.11.2013
ES20.11.2013
FI20.11.2013
HR20.11.2013
LT20.11.2013
LV20.11.2013
NL20.11.2013
SE20.11.2013
NO20.02.2014
IS20.03.2014
Former [2014/25]AT20.11.2013
ES20.11.2013
FI20.11.2013
HR20.11.2013
LT20.11.2013
LV20.11.2013
NL20.11.2013
SE20.11.2013
NO20.02.2014
IS20.03.2014
Former [2014/24]AT20.11.2013
ES20.11.2013
FI20.11.2013
HR20.11.2013
LT20.11.2013
NL20.11.2013
SE20.11.2013
NO20.02.2014
IS20.03.2014
Former [2014/23]FI20.11.2013
HR20.11.2013
LT20.11.2013
NL20.11.2013
SE20.11.2013
NO20.02.2014
IS20.03.2014
Former [2014/22]FI20.11.2013
LT20.11.2013
NL20.11.2013
SE20.11.2013
NO20.02.2014
Former [2014/20]LT20.11.2013
NO20.02.2014
Cited inInternational search[Y]US5880118  (BARBACHYN MICHAEL R [US], et al) [Y] 1-10* example 1; claims 8,19 *;
 [I]  - CYNAMON M H ET AL, "Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, (199905), vol. 43, no. 5, ISSN 0066-4804, pages 1189 - 1191, XP002557656 [I] 1-10 * page 1190, paragraph 2; table 3 *
 [Y]  - BALLELL L ET AL, "NEW SMALL-MOLECULE SYNTHETIC ANTIMYCOBACTERIALS", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US, (20050601), vol. 49, no. 6, ISSN 0066-4804, pages 2153 - 2163, XP008056050 [Y] 1-10 * page 2160 - column 2, paragraph 4; table 2; compound 44 * * page 2153, column 1, paragraph 2 *

DOI:   http://dx.doi.org/10.1128/AAC.49.6.2153-2163.2005
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.